ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $352,000 | -82.1% | 162,300 | -70.7% | 0.00% | -75.0% |
| Q3 2021 | $1,970,000 | -36.1% | 553,324 | +3.0% | 0.00% | -42.9% |
| Q2 2021 | $3,083,000 | +40.9% | 537,121 | +27.4% | 0.01% | +16.7% |
| Q1 2021 | $2,188,000 | +504.4% | 421,542 | +122.3% | 0.01% | +200.0% |
| Q2 2020 | $362,000 | +1031.2% | 189,649 | +1358.8% | 0.00% | – |
| Q1 2020 | $32,000 | -27.3% | 13,000 | -37.8% | 0.00% | – |
| Q3 2019 | $44,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |